Oncology Today with Dr Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Latest episodes
Apr 12, 2023 • 1h 17min
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
Dr John Allan from Weill Cornell Medicine in New York City discusses the most important chronic lymphocytic leukemia studies presented at ASH 2022.
CME information and select publications here.
Mar 2, 2023 • 1h 28min
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha, Nebraska, discusses the most important lymphoma studies presented at the 2022 ASH Annual Meeting.
CME information and select publications here.
Feb 28, 2023 • 54min
Management of Desmoid Tumors with Dr Mrinal Gounder
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York City discusses the management of desmoid tumors.
CME information and select publications here.
Feb 21, 2023 • 1h 20min
Management of HER2-Altered Non-Small Cell Lung Cancer
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer.
CME information and select publications here.
Feb 13, 2023 • 50min
Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
Dr Edward Garon from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, discusses the management of NSCLC in patients who do not have actionable activating mutations.
CME information and select publications here.
Feb 9, 2023 • 1h 19min
Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek
Dr Srdan Verstovsek from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses new data with myeloproliferative neoplasms presented at the 2022 ASH Annual Meeting.
CME information and select publications here.
Feb 6, 2023 • 44min
Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York City discusses recent data from clinical trials evaluating targeted therapies for diffuse large B-cell lymphoma.
CME information and select publications here.
Feb 2, 2023 • 1h 10min
Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone
Dr Richard Stone from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses new data in acute myeloid leukemia and myelodysplastic syndromes presented at the 2022 ASH Annual Meeting.
CME information and select publications here.
Jan 31, 2023 • 1h 40min
Special Edition — Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan
Dr Erica Mayer from the Dana-Farber Cancer Institute in Boston, Massachusetts and Dr Ruth O'Regan from the University of Rochester in Rochester, New York discuss new developments in ER-positive breast cancer.
CME information and select publications here.
Jan 26, 2023 • 47min
HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano
Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy discusses recent therapeutic advances in HER2-positive metastatic breast cancer.
CME information and select publications here.
